Related Experiment Video

Updated: Jun 19, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery study

Mehmet Ozaydin1

  • 1Suleyman Demirel University, Department of Cardiology, School of Medicine, Isparta, Turkey. mehmetozaydin@hotmail.com

Future Cardiology
|October 7, 2009
PubMed

Insights

Atorvastatin significantly reduced post-operative atrial fibrillation and hospital stay in cardiac surgery patients. This suggests atorvastatin may be beneficial for patients undergoing cardiac procedures.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Post-operative atrial fibrillation (AF) is a common complication after cardiac surgery.
  • Statins have shown pleiotropic effects, including anti-inflammatory and anti-arrhythmic properties.
  • The ARMYDA-3 study investigated the role of atorvastatin in preventing post-operative AF.

Purpose of the Study:

  • To evaluate the efficacy of atorvastatin in reducing the incidence of post-operative atrial fibrillation (AF) after cardiac surgery.
  • To assess the impact of atorvastatin on the duration of hospital stay in these patients.

Main Methods:

  • A randomized, placebo-controlled trial was conducted.
  • Patients received either atorvastatin 40 mg/day or placebo for one week prior to cardiac surgery.
  • Post-operative AF incidence and hospital stay duration were primary endpoints.

Main Results:

  • Atorvastatin significantly reduced the rate of post-operative AF compared to placebo.
  • The mean post-operative hospital stay was significantly shorter in the atorvastatin group.
  • The composite endpoint at one month showed similar incidence in both groups.

Conclusions:

  • Initiating atorvastatin prior to cardiac surgery can reduce the incidence of post-operative AF.
  • Atorvastatin therapy may also decrease the duration of hospital stay in cardiac surgery patients.
  • Further research is needed to confirm these findings for all statins and in broader patient populations.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...